Viewing Study NCT02188368


Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2025-12-27 @ 4:19 AM
Study NCT ID: NCT02188368
Status: TERMINATED
Last Update Posted: 2023-11-03
First Post: 2014-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Sponsor: Oncotherapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multiple myeloma View
None Pomalidomide View
None Lenalidomide refractory View